Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?
Anna Gil-Sánchez, Hugo Gonzalo, Marc Canudes, et al.
Molecular Neurobiology
|
June 17, 2026
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis
Pascual Torres, Anna Gil Sánchez, Agustín Sancho-Saldaña, et al.
International Journal of Medical Sciences
|
August 29, 2013
Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures
José M Palanca, Diana Aguirre-Rueda, Manuel V Granell, et al.
Journal of Neurology
|
March 18, 2023
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
Pascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, et al.
Scientific Reports
|
November 8, 2023
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
Cristina González Mingot, Sonia Santos Lasaosa, Laura Colàs Campàs, et al.
Journal of Clinical Medicine
|
June 13, 2025
Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months
Agustín Sancho-Saldaña, Anna Gil-Sánchez, Bibiana Quirant-Sánchez, et al.
Frontiers in Neuroscience
|
September 26, 2019
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Hugo Gonzalo, Lara Nogueras, Anna Gil-Sánchez, et al.
Journal of Clinical Medicine
|
May 14, 2022
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
Agustín Sancho-Saldaña, Anna Gil Sánchez, Bibiana Quirant-Sánchez, et al.
The International Journal of Neuroscience
|
May 5, 2016
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients
Anna Gil Sánchez, Eugenia Lacasa Andrade, Joan Valls Marsal, et al.
Frontiers in Rehabilitation Sciences
|
January 6, 2023
Cognitive assessment in patients with multiple sclerosis: A Spanish consensus
Yolanda Higueras, Mónica Borges, Isabel Jiménez-Martín, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Pharmaceuticals (Basel, Switzerland)
|
April 27, 2024
Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?
Anna Gil-Sánchez, Hugo Gonzalo, Marc Canudes, et al.
Molecular Neurobiology
|
June 17, 2026
18:2 Cholesterol Ester is a Novel Prognostic Biomarker of Disease Progression in Multiple Sclerosis
Pascual Torres, Anna Gil Sánchez, Agustín Sancho-Saldaña, et al.
International Journal of Medical Sciences
|
August 29, 2013
Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures
José M Palanca, Diana Aguirre-Rueda, Manuel V Granell, et al.
Journal of Neurology
|
March 18, 2023
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
Pascual Torres, Agustín Sancho-Saldaña, Anna Gil Sánchez, et al.
Scientific Reports
|
November 8, 2023
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
Cristina González Mingot, Sonia Santos Lasaosa, Laura Colàs Campàs, et al.
Journal of Clinical Medicine
|
June 13, 2025
Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months
Agustín Sancho-Saldaña, Anna Gil-Sánchez, Bibiana Quirant-Sánchez, et al.
Frontiers in Neuroscience
|
September 26, 2019
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Hugo Gonzalo, Lara Nogueras, Anna Gil-Sánchez, et al.
Journal of Clinical Medicine
|
May 14, 2022
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
Agustín Sancho-Saldaña, Anna Gil Sánchez, Bibiana Quirant-Sánchez, et al.
The International Journal of Neuroscience
|
May 5, 2016
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients
Anna Gil Sánchez, Eugenia Lacasa Andrade, Joan Valls Marsal, et al.
Frontiers in Rehabilitation Sciences
|
January 6, 2023
Cognitive assessment in patients with multiple sclerosis: A Spanish consensus
Yolanda Higueras, Mónica Borges, Isabel Jiménez-Martín, et al.
Page
of 5